Hush money trial: Trump's lawyers will grill tabloid publisher David Pecker
Time:2024-05-21 19:52:57 Source:styleViews(143)
NEW YORK (AP) — After prosecutors’ lead witness painted a tawdry portrait of “catch and kill” tabloid schemes, defense lawyers in Donald Trump’s hush money trial are poised Friday to dig into an account of the former publisher of the National Enquirer and his efforts to protect Trump from negative stories during the 2016 election.
David Pecker will return to the witness stand for the fourth day as defense attorneys try to poke holes in the testimony of the former National Enquirer publisher, who has described helping bury embarrassing stories Trump feared could hurt his campaign.
It will cap a consequential week in the criminal cases the former president is facing as he vies to reclaim the White House in November.
At the same time jurors listened to testimony in Manhattan, the Supreme Court on Thursday signaled it was likely to reject Trump’s sweeping claims that he is immune from prosecution in his 2020 election interference case in Washington. But the conservative-majority high court seemed inclined to limit when former presidents could be prosecuted — a ruling that could benefit Trump by delaying that trial, potentially until after the November election.
Previous:Lynn Williams breaks NWSL goal
Next:Amtrak train hits pickup truck in upstate New York, 3 dead including child
You may also like
- Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
- Ukraine war: Five dead and a million without power after wave of Russian strikes
- Human Rights Commission advises caution over boot camps
- Mediaworks data breach: Hackers email victims, demanding $820
- Georgia Republicans choose Amy Kremer, organizer of pro
- New Zealand to put 'every single effort' into getting free trade deal with India
- Far North councillors vote 9 to 1 to seek delay in adding fluoride to water supply
- Scientists find 'devastating' coral bleaching in Great Barrier Reef's far north
- Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient